Literature DB >> 11819752

Effects of Taxotere on invasive potential and multidrug resistance phenotype in pancreatic carcinoma cell line SUIT-2.

B Liu1, E Staren, T Iwamura, H Appert, J Howard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11819752      PMCID: PMC4688693          DOI: 10.3748/wjg.v7.i1.143

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  40 in total

1.  Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique.

Authors:  G F Greene; Y Kitadai; C A Pettaway; A C von Eschenbach; C D Bucana; I J Fidler
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Growth-inhibiting effects of taxol on human liver cancer in vitro and in nude mice.

Authors:  Jin-Hui Yuan; Ru-Ping Zhang; Ru-Gang Zhang; Li-Xia Guo; Xing-Wang Wang; Dan Luo; Yong Xie; Hong Xie
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

3.  Emergence of higher levels of invasive and metastatic properties in the drug resistant cancer cell lines after the repeated administration of cisplatin in tumor-bearing mice.

Authors:  M Mitsumoto; T Kamura; H Kobayashi; T Sonoda; T Kaku; H Nakano
Journal:  J Cancer Res Clin Oncol       Date:  1998       Impact factor: 4.553

4.  Multidrug resistance and malignancy in human osteosarcoma.

Authors:  K Scotlandi; M Serra; G Nicoletti; M Vaccari; M C Manara; G Nini; L Landuzzi; A Colacci; G Bacci; F Bertoni; P Picci; M Campanacci; N Baldini
Journal:  Cancer Res       Date:  1996-05-15       Impact factor: 12.701

5.  Heterogeneities of attachment, chemotaxis, and protease production among clones with different metastatic potentials from a human pancreatic cancer cell line.

Authors:  S Taniguchi; T Iwamura; N Kitamura; H Yamanari; T Setoguchi
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

6.  Metastatic potential and multidrug resistance correlation in the B16 melanoma system.

Authors:  A N Staroselsky; T Mahlin; N Savion; O Klein; J Nordenberg; N Donin; M Michowitz; J Leibovici
Journal:  J Exp Ther Oncol       Date:  1996-07

7.  Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro.

Authors:  B T Hill; R D Whelan; S A Shellard; S McClean; L K Hosking
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

Review 8.  Multidrug resistance and behavioural phenotype of cancer cells.

Authors:  I Bashir; K Sikora; C S Foster
Journal:  Cell Biol Int       Date:  1993-10       Impact factor: 3.612

9.  Paclitaxel (Taxol(R)) inhibits motility of paclitaxel-resistant human ovarian carcinoma cells.

Authors:  D Belotti; M Rieppi; M I Nicoletti; A M Casazza; T Fojo; G Taraboletti; R Giavazzi
Journal:  Clin Cancer Res       Date:  1996-10       Impact factor: 12.531

10.  Cytoskeletal filament assembly and the control of cell spreading and function by extracellular matrix.

Authors:  D J Mooney; R Langer; D E Ingber
Journal:  J Cell Sci       Date:  1995-06       Impact factor: 5.285

View more
  10 in total

1.  Effect of mitogen-activated protein kinase signal transduction pathway on multidrug resistance induced by vincristine in gastric cancer cell line MGC803.

Authors:  Bo Chen; Feng Jin; Ping Lu; Xiang-Lan Lu; Ping-Ping Wang; Yun-Peng Liu; Fan Yao; Shu-Bao Wang
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

2.  Expression and function of classical protein kinase C isoenzymes in gastric cancer cell line and its drug-resistant sublines.

Authors:  Ying Han; Zhe-Yi Han; Xin-Min Zhou; Ru Shi; Yue Zheng; Yong-Quan Shi; Ji-Yan Miao; Bo-Rong Pan; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

3.  Taxotere resistance in SUIT Taxotere resistance in pancreatic carcinoma cell line SUIT 2 and its sublines.

Authors:  B Liu; E Staren; T Iwamura; H Appert; J Howard
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

4.  Effect of ZNRD1 gene antisense RNA on drug resistant gastric cancer cells.

Authors:  Yu-Mei Zhang; Yan-Qiu Zhao; Yang-Lin Pan; Yong-Quan Shi; Xiao-Hang Jin; Hui Yi; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

5.  Differential display of vincristine-resistance-related genes in gastric cancer SGC7901 cell.

Authors:  Xin Wang; Mei Lan; Yong-Quan Shi; Ju Lu; Yue-Xia Zhong; Han-Ping Wu; Hui-Hong Zai; Jie Ding; Kai-Cun Wu; Bo-Rong Pan; Jian-Ping Jin; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

6.  Correlation of CT enhancement, tumor angiogenesis and pathologic grading of pancreatic carcinoma.

Authors:  Zhong-Qiu Wang; Jie-Shou Li; Guang-Ming Lu; Xin-Hua Zhang; Zi-Qian Chen; Kui Meng
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

7.  Inhibitory effects of docetaxel on expression of VEGF, bFGF and MMPs of LS174T cell.

Authors:  Xue-Liang Guo; Geng-Jin Lin; Hong Zhao; Yong Gao; Li-Ping Qian; San-Rong Xu; Li-Na Fu; Qing Xu; Jie-Jun Wang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

8.  Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R.

Authors:  Jia-Yin Yang; Hua-You Luo; Qi-Yuan Lin; Zi-Ming Liu; Lu-Nan Yan; Ping Lin; Jie Zhang; Shong Lei
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

9.  Relationship between nuclear morphometry, DNA content and resectability of pancreatic cancer.

Authors:  Yin-Cheng He; Wei Peng; Jian-Guo Qiao; Jun Cao; Ji-Wei Chen
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

10.  K-ras gene mutation in the diagnosis of ultrasound guided fine-needle biopsy of pancreatic masses.

Authors:  Min Zheng; Lian-Xin Liu; An-Long Zhu; Shu-Yi Qi; Hong-Chi Jiang; Zhu-Ying Xiao
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.